- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Boule Diagnostics AB (BOUL)
Boule Diagnostics AB stock price live, this page displays ST BOUL stock exchange data. View the BOUL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Boule Diagnostics AB real time stock price chart below.
What Is the Boule Diagnostics AB Stock Price Today?
The Boule Diagnostics AB stock price today is 8.02.
What Is the Stock Symbol for Boule Diagnostics AB?
The stock symbol for Boule Diagnostics AB is "BOUL."
What Stock Exchange Does Boule Diagnostics AB Trade On?
Boule Diagnostics AB is listed and trades on the Stockholm stock exchange.
Is Boule Diagnostics AB a Good Stock to Buy?
Determining whether Boule Diagnostics AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BOUL quote. (ISIN: SE0011231158)
What Is the Boule Diagnostics AB Stock Price Today?
The Boule Diagnostics AB stock price today is 8.02.
What Is the Stock Symbol for Boule Diagnostics AB?
The stock symbol for Boule Diagnostics AB is "BOUL."
What Stock Exchange Does Boule Diagnostics AB Trade On?
Boule Diagnostics AB is listed and trades on the Stockholm stock exchange.
Is Boule Diagnostics AB a Good Stock to Buy?
Determining whether Boule Diagnostics AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BOUL quote. (ISIN: SE0011231158)
Stockholm
Currency in SEK
8.02
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.94
8.16
52 wk Range
6.50
10.90
BOUL Scorecard
Full Analysis
Net income is expected to grow this year
BOUL is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.948.16
52 wk Range
6.5010.90
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BOUL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
10.30
Upside
+28.43%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Not profitable over the last twelve months
Boule Diagnostics AB Company Profile
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics companies. Boule Diagnostics AB (publ) was founded in 1956 and is headquartered in Spånga, Sweden.
Boule Diagnostics AB Earnings Call Summary for Q1/2025
- Q1 2025 sales down 23.6% YoY to SEK 113M, but adjusted EBIT margin reached 15.1%, highest since 2020
- Implementing technology partner strategy and transitioning to license manufacturing in India to mitigate geopolitical risks
- Aiming for positive operating cash flow in H2 2025; expanding clinical chemistry distribution in US by Q3
- CEO emphasizes focus on operational efficiency and expanding operating margin
- Analysts forecast positive EPS of $0.13 for FY2025, despite current challenges
Last Updated: 2025/04/28, 11:00
Read Full TranscriptCompare BOUL to Peers and Sector
Metrics to compare | BOUL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBOULPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.0x | 0.0x | −0.5x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 1.8x | 0.0x | 2.6x | |
Price / LTM Sales | 0.6x | 0.0x | 3.0x | |
Upside (Analyst Target) | 28.4% | 0.0% | 52.6% | |
Fair Value Upside | Unlock | 0.0% | 8.8% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 10.30
(+28.43% Upside)
Earnings
Latest Release
Apr 28, 2025
EPS / Forecast
0.3399 / 0.39
Revenue / Forecast
112.90M / 144.95M
FAQ
What Is the Boule Diagnostics (BOUL) Stock Price Today?
The Boule Diagnostics stock price today is 8.02
What Stock Exchange Does Boule Diagnostics Trade On?
Boule Diagnostics is listed and trades on the Stockholm Stock Exchange stock exchange.
What Is the Stock Symbol for Boule Diagnostics?
The stock symbol for Boule Diagnostics is "BOUL."
What Is the Boule Diagnostics Market Cap?
As of today, Boule Diagnostics market cap is 311.44M.
What Is Boule Diagnostics's Earnings Per Share (TTM)?
The Boule Diagnostics EPS (TTM) is -8.21.
When Is the Next Boule Diagnostics Earnings Date?
Boule Diagnostics will release its next earnings report on 17 Jul 2025.
From a Technical Analysis Perspective, Is BOUL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Boule Diagnostics Stock Split?
Boule Diagnostics has split 1 times.
How Many Employees Does Boule Diagnostics Have?
Boule Diagnostics has 200 employees.
What is the current trading status of Boule Diagnostics (BOUL)?
As of 21 Jun 2025, Boule Diagnostics (BOUL) is trading at a price of 8.02, with a previous close of 8.02. The stock has fluctuated within a day range of 7.94 to 8.16, while its 52-week range spans from 6.50 to 10.90.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.